About Julie Krop

Creative, strategic physician-leader with a breadth of clinical development and regulatory experience across multiple therapeutic and orphan indications in the biopharmaceutical industry. Prior roles include senior leadership positions across Clinical Development and Regulatory Affairs in large pharma as well as medium and small sized biotech companies. Extensive experience in early and late stage development of both orphan and non-orphan drug candidates through approval and post-approval life cycle management. Strong regulatory background including leading pre-IND meetings, EOP2 meetings, US and EMEA filings for approval, and FDA advisory panels. Unique combination of strong technical skills with a strategic, practical and entrepreneurial focus on successfully driving the business forward.